Status:
COMPLETED
Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Migraine
Headache
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This investigation describes a proposed clinical trial that will evaluate the relative efficacy of intravenous magnesium sulfate for the treatment of migraine compared to intravenous metoclopramide (R...
Detailed Description
Migraine or severe headache affected one-fifth of women and one-tenth of men in 2015 and is one of the leading causes of disability in the world. Over one million visits to emergency departments (ED) ...
Eligibility Criteria
Inclusion
- Age \> 18 years or older
- Able to provide informed consent
- Primary diagnosis of headache or migraine
- Between October 1, 2018 to April 1, 2020
- Presenting to Advocate Christ Medical Center emergency department and meet clinical assessment per physician
Exclusion
- Pregnancy defined as a positive urine HCG
- Stated history of renal impairment
- Allergy or sensitivity to any study drugs
- Concomitant treatment at the time of study drug administered in the emergency department
- Patients with a history of this study participation
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2023
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT05967442
Start Date
August 23 2019
End Date
April 6 2023
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advocate Christ Medical Center
Oak Lawn, Illinois, United States, 60453